Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
The sudden appearance of overt human Zika virus infections that cross the placenta to damage fetal tissues, target sexual organs, and are followed in some instances by Guillain-Barré syndrome raises questions regarding whether these outcomes are caused by genetic mutations or if prior infection by o...
Main Author: | Scott B. Halstead |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2017-04-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/23/4/16-1879_article |
Similar Items
-
Low to medium-low risk perception for dengue, chikungunya and Zika outbreaks by infectious diseases physicians in France, Western Europe
by: Marion Le Tyrant, et al.
Published: (2019-07-01) -
Two Lineages of Dengue Virus Type 2, Brazil
by: Michelli Faria Oliveira, et al.
Published: (2010-03-01) -
The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil
by: Paolo Marinho de Andrade Zanotto, et al.
Published: (2018-08-01) -
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
by: Matthew H. Collins, et al.
Published: (2017-05-01) -
Early Genomic Detection of Cosmopolitan Genotype of Dengue Virus Serotype 2, Angola, 2018
by: Sarah C. Hill, et al.
Published: (2019-04-01)